Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cleveland BioLabs To Form Joint Venture In Russia
As per the agreement, BioLabs will transfer rights to its pipeline of Curaxin anticancer molecules to the joint venture, and BCV will fund about $15 million in three
As per the agreement, BioLabs will transfer rights to its pipeline of Curaxin anticancer molecules to the joint venture, and BCV will fund about $15 million in three
The trials, termed as EXPEDITION and EXPEDITION 2, are identical multicenter, randomized, double-blind and placebo-controlled trials. Each will include a treatment period that lasts one and half year
Cougar is currently conducting two Phase III trials for abiraterone acetate for the treatment of prostate cancer. The first Phase III trial is testing abiraterone acetate in patients
Last October, the company submitted a new drug application to the US Food and Drug Administration (FDA) requesting marketing approval of Qutenza. In December 2008, it was accepted
These studies showed survival benefit in two relevant animal species, which is the minimum requirement for establishing the efficacy of new drugs used in countering bioterrorism. Raxibacumab is
In the oral decision, the District Court dismissed all of the claims filed by MGH except that made under Massachusetts General Law chapter 93A, a consumer protection law
The company has signed an agreement to sell its calcium chloride business to a strategic chemical industry buyer for a value in excess of $210m. Employees of the
SOCMA said it is unclear if EPA will use the additional time to reconsider establishing a de minimis threshold. SOCMA had earlier, urged EPA to establish a de
The phase I trial will be conducted on about 30 to 40 patients suffering from solid tumours and had gone through all the treatments available at present. Following
Ernest Egli, President of Roche, Latin America, said: “moksha8 has produced strong results for Roche in Brazil and we are delighted to expand our relationship to include Mexico